The Pharmcast

By YourEncore, Inc.

Science & Medicine Business Management & Marketing

What's The Pharmcast about?

YourEncore's Pharmcast is your weekly dose of wisdom from today's top life science minds. Each week in the Pharmcast, we talk with top industry experts in our network or beyond about hot industry topics, leadership, and the path to success.

Download our free app to listen on your phone

The Pharmcast episodes:

06.14.2017
How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20)
In this episode of The Pharmcast, we join YourEncore Expert, Darryl Glover, to discuss one of the hottest technologies on the market today: blockchain. We've heard some people say that if the internet was invented today, it would be built...
05.11.2017
State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19)
In this episode of The Pharmcast, we share a recording from our May 5th webinar, State of the Industry: U.S. Regulatory Policy Overview. Parthenon-EY and YourEncore recently conducted a nationwide survey of life sciences experts to query them on recent market...
04.30.2017
The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18)
This week in the Pharmcast, we caught up with Dr. Tim Franson to discuss the leading edge of rare disease drug development. Dr. Franson has been actively helping Parent Project Muscular Dystrophy, a Duchenne Muscular Dystrophy Patient Advocacy group, which...
04.13.2017
Welcome to the Real World: A Reality Check for Digital Health with Dr. Ron Razmi (Ep. 17)
This week on The Pharmcast, we tackle one of the hottest topics in the life sciences and healthcare industry: digital health. The promise of digital health is enticing, and a logical evolution of the digital economy. However, some of the...
03.22.2017
Best Practices in Biologics Launch Communications: Doing It Better Than You've Ever Done It (Ep. 16 of The Pharmcast)
On this episode of The Pharmcast, Heidi Youngkin shares her formula to successful launch communications for biologics. Heidi Youngkin is a 13-year veteran from Johnson & Johnson, where she served as the Executive Global Director of Global Pharmaceutical Communications and...
03.15.2017
The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)
On this week's episode of The Pharmcast, we talk with YourEncore Expert, Philippe Barzin, on the future of big data and artificial intelligence in oncology. Based off Philippe's article, Artificial Intelligence Fighting Cancer and Transforming Public Health, we talk with Philippe...
03.02.2017
Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)
On this week's episode of The Pharmcast, we explore the key elements of an effective regulatory strategy and how to drive value to patient and shareholders by working with the FDA. We also cover common ways agency decisions can destroy...
02.16.2017
Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)
We are at a time of great change and transition in the FDA. The sitting FDA chief stepped down, just when the 21st Century Cures Act passed into law; PDUFA 6 is up for renewal this year; and the new...
02.10.2017
4 NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 of The Pharmcast)
This week on the Pharmcast, we talk with Dr. Joseph Lamendola on four New Drug Application (NDA) mistakes to avoid. Dr. Lamendola is the former VP of U.S. Regulatory Affairs for Bristol-Myers Squibb and Schering-Plough, and now serves as the SVP...
02.06.2017
Medtech Valuation Killers: 10 Regulatory & Commercialization Traps to Avoid (Ep. 11 of The Pharmcast)
In this week's episode of The Pharmcast, we talk with Dr. Janet Vargo and Minnie Baylor-Henry, J.D. to share 10 mistakes medical device start-ups frequently make during development that ultimately reduce their valuation to potential acquirers. After evaluating dozens of...
01.27.2017
Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)
This week on The Pharmcast, we turn our attention to the topic of rare disease, and more specifically: how to engage and educate rare disease patients to advance development. It's estimated that nearly 30 million Americans, or nearly 1 in 10 people,...
01.19.2017
No Surprises: Improving Medical Devices Due Diligence (Ep. 9 of The Pharmcast)
In this week's episode of The Pharmcast, we join two former Johnson & Johnson medical devices executives - Donna Godward and Dr. Janet Vargo - to discuss M&A; due diligence and best practices. In this session, Donna Godward and Dr....
01.11.2017
FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 of The Pharmcast)
This week on The Pharmcast, we talk with Judith Meritz, J.D. (Former Associate General Counsel at Covidien/Medtronic), and Victor Chance (Former Vice President of External Operations and Chief Supply Chain Chief Procurement Officer for J&J; Medical Devices and Diagnostics), as they outline the most...
01.04.2017
Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr. Don Therasse (Ep. 7 of The Pharmcast)
This week on The Pharmcast, we talk with Dr. Don Therasse, former VP of Global Patient Safety for Eli Lilly & Company, and current Strategic Advisor for YourEncore. Beyond drug safety, Don Therasse is a thought leader in...
12.14.2016
From Big Pharma to the Biotech C-Suite and Beyond: Industry and Career Insights from Dr. June Almenoff (Ep. 6 of The Pharmcast)
This week on The Pharmcast, we talk with Dr. June Almenoff, former President, Chief Medical Officer and Board Member of a biotech, which was recently acquired in 2014 by Forest Laboratories for $1.2 billion. Almenoff helped the company successfully progress its...
12.07.2016
Holiday Wishes and Watch-Outs from Regulatory Leaders (Ep. 5 of The Pharmcast)
This week in The Pharmcast, we asked two of our top regulatory policy Experts to give us their holiday wish-lists, and top things to watch for in 2017. Leading the discussion is Dr. Tim Franson, who is the former VP...
11.30.2016
Billion Dollar Bets: Lessons on Innovation from a BMS Chief Scientific Officer, Dr. Elliott Sigal (Ep. 4 of The Pharmcast)
This week in The Pharmcast, we catch up with Dr. Elliott Sigal, former Chief Scientific Officer of Bristol-Myers Squibb. In 2012, The Wall Street Journal called Dr. Sigal "The Best R&D; Chief in Pharma," largely for helping deliver BMS' "String of Pearls"...
11.16.2016
9 Biotech Valuation Killers (Ep. 3 of The Pharmcast)
According to a global study by Mergermarket and Reed Smith, 94 percent of senior life sciences executives plan to make an acquisition in 2016, so biotech firms need to do everything possible to make sure they are properly positioned to...
10.27.2016
BMS Transformation: Part 2 (Ep. 2 of The Pharmcast)
A continuation of our maiden voyage of the Pharmcast, we talk with a trio of former Bristol-Myers Squibb executives, who developed and delivered BMS’ “String of Pearls” strategy, that delivered first-class medicines to patients and positioned BMS as a clear leader...

What's The Pharmcast about?

Download our free app to listen on your phone

The Pharmcast episodes:

How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20)

State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19)

The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18)

Welcome to the Real World: A Reality Check for Digital Health with Dr. Ron Razmi (Ep. 17)

Best Practices in Biologics Launch Communications: Doing It Better Than You've Ever Done It (Ep. 16 of The Pharmcast)

The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

4 NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 of The Pharmcast)

Medtech Valuation Killers: 10 Regulatory & Commercialization Traps to Avoid (Ep. 11 of The Pharmcast)

Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

No Surprises: Improving Medical Devices Due Diligence (Ep. 9 of The Pharmcast)

FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 of The Pharmcast)

Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr. Don Therasse (Ep. 7 of The Pharmcast)

From Big Pharma to the Biotech C-Suite and Beyond: Industry and Career Insights from Dr. June Almenoff (Ep. 6 of The Pharmcast)

Holiday Wishes and Watch-Outs from Regulatory Leaders (Ep. 5 of The Pharmcast)

Billion Dollar Bets: Lessons on Innovation from a BMS Chief Scientific Officer, Dr. Elliott Sigal (Ep. 4 of The Pharmcast)

9 Biotech Valuation Killers (Ep. 3 of The Pharmcast)

BMS Transformation: Part 2 (Ep. 2 of The Pharmcast)